Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Sny save search
Gorman-Rupp Company Declares Cash Dividend – Business Wire
Published: 2023-04-28 (Crawled : 11:00) - spacfeed.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.21%
H: 0.12%
C: -2.76%
BY 4 | $20.72 3.19% 0.0% 93K
|
Finance
|
| O: 4.74%
H: 0.0%
C: -3.83%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
NDRA | $0.2334 1.11% 68K
|
Health Technology
|
| O: -20.16%
H: 70.87%
C: 55.34%
business
IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement with Sanofi
Published: 2022-03-29 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: 42.23%
H: 68.76%
C: 38.32%
conference collaboration
Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets
Published: 2022-03-29 (Crawled : 09:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: 42.23%
H: 68.76%
C: 38.32%
collaboration immunology
IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-29 (Crawled : 11:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: 42.23%
H: 68.76%
C: 38.32%
results
DarioHealth Reports Third Quarter 2023 Financial and Operating Results
Published: 2023-11-02 (Crawled : 11:00) - biospace.com/
AMWL | $0.5466 5.54% -0.22% 2.1M
|
Technology Services
|
| O: -6.78%
H: 22.73%
C: 21.82%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.0%
H: 0.0%
C: 0.0%
DRIO | $1.17 1.74% 1.71% 50K
|
Health Technology
|
| O: -26.73%
H: 36.49%
C: 36.49%
financial results
Europe Frontotemporal Dementia Market Research Report 2023: Growing Prevalence of Dementia & Increasing Number of Clinical Trials - Competition, Forecasts & Opportunities to 2028
Published: 2023-04-26 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.57%
H: 0.22%
C: -1.98%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.22%
H: 0.65%
C: -1.09%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: -2.04%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.66%
H: 0.18%
C: -0.9%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.3%
C: -2.63%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
CNTG | $0.463 0.43% 0.43% 79K
|
Commercial Services
|
| O: 1.23%
H: 27.27%
C: -15.76%
europe report dementia trials research growing market
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses
Published: 2023-05-09 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 20.4%
H: 26.64%
C: 6.13%
covid vaccine positive influenza topline results show
Regeneron Reports Second Quarter 2021 Financial and Operating Results
Published: 2021-08-05 (Crawled : 11:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 1.32%
H: 2.47%
C: 2.35%
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: -2.46%
H: 24.2%
C: 15.24%
results
Hemophilia B (Factor IX Deficiency) Drugs In Development, 2021
Published: 2021-09-06 (Crawled : 19:00) - prnewswire.com
SGTX | $22.47 -2.56% 0.0% 0
|
Health Technology
|
| O: 1.98%
H: 21.87%
C: 14.11%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.02%
H: 0.08%
C: -0.21%
FRLN | $6.48 0.0% 0
|
Health Technology
|
| O: -2.21%
H: 2.76%
C: 1.0%
drug
First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
Published: 2023-09-14 (Crawled : 10:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.14%
H: 0.0%
C: -1.3%
FWBI | $2.59 -8.8% -9.65% 83K
|
Manufacturing
|
| O: 109.38%
H: 21.84%
C: -44.24%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.74%
C: 0.33%
license biopharma global agreement sanofi
Kymera Therapeutics Announces Third Quarter 2023 Financial Results and Provides a Business Update
Published: 2023-11-02 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.0%
H: 0.0%
C: 0.0%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: -12.64%
H: 20.32%
C: 19.72%
business update therapeutics financial results
BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.98%
H: 0.73%
C: -1.19%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.49%
H: 0.72%
C: -0.36%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 2.61%
H: 20.19%
C: 14.8%
acquisition therapy
Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials
Published: 2023-05-01 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 4.08%
H: 0.0%
C: 0.0%
ELDN | $1.85 -7.03% -7.57% 420K
|
Manufacturing
|
| O: 1.43%
H: 18.78%
C: 7.98%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
kidney pharmaceuticals trials
R&D Day Highlights Kymera’s Immunology Strategy and Emerging Pipeline of Novel, First-in-Class Oral Degraders Addressing Multiple Highly Prevalent Immuno-inflammatory Diseases
Published: 2024-01-04 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.12%
H: 0.93%
C: 0.77%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 0.79%
H: 18.72%
C: 17.94%
day pipeline immunology
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: 18.06%
H: 17.95%
C: 17.1%
business year therapeutics financial results
Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
Published: 2023-07-18 (Crawled : 05:00) - prnewswire.com
KA A | $0.5196 6.89% 6.45% 480K
|
Manufacturing
|
| O: 0.0%
H: 16.64%
C: 8.56%
XFOR | $1.255 4.58% 4.38% 3M
|
Health Technology
|
| O: 0.56%
H: 0.56%
C: -3.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
APRE | $5.65 0.71% 0.71% 7.2K
|
Health Technology
|
| O: 5.16%
H: 53.39%
C: 3.24%
Prelude Therapeutics Announces Appointment of Martin Babler to its Board of Directors
Published: 2021-07-19 (Crawled : 12:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.03%
H: 1.04%
C: 0.97%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.68%
H: 0.41%
C: -0.31%
PRLD | $3.81 10.76% 9.71% 58K
|
Health Technology
|
| O: -2.4%
H: 15.87%
C: 11.88%
Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation TherapiesExpansion of agreement results in an additional payment of $22 million to Nurix
Published: 2021-01-07 (Crawled : 19:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.27%
H: 0.44%
C: 0.44%
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: 0.52%
H: 15.42%
C: 14.2%
collaboration expansion
IGM Announces Proposed Public Offering and Concurrent Private Placement
Published: 2023-06-21 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.73%
H: 0.09%
C: -0.6%
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: 2.65%
H: 14.83%
C: 4.84%
offering
IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement
Published: 2023-06-22 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.73%
H: 0.09%
C: -0.6%
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: 2.65%
H: 14.83%
C: 4.84%
offering
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
NYC 4 | $5.91 -4.83% 14.38% 770
|
Finance
MGOL 4 | $0.229 -4.18% 13.72% 420K
|
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
DEO | News | $140.76 -0.02% 8.27% 560K
|
Consumer Non-Durables
KUKE | $2.88 2.49% 7.64% 360K
|
MGLD 4 | $1.23 8.85% 7.32% 14K
|
Manufacturing
GRFX | $0.2116 -1.58% 7.28% 40K
|
n/a
LYT | $4.22 4.72% 5.62% 1.4M
|
SYY | $76.73 1.44% 5.49% 2.5M
|
Distribution Services
Your saved searches
Save your searches and get alerts when important news are released.